English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52879834    在线人数 :  704
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"hsu c"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 31-40 / 881 (共89页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-06-27T07:07:53Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; CHONG-JEN YU; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2022-06-27T07:06:40Z Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials Kuo S.-H.; Yang C.-H.; CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:37Z Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:33Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang C.-H.; Shih J.-Y.; Chen K.-C.; CHONG-JEN YU; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:23Z Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers Chen J.-P.; Lo Y.; CHONG-JEN YU; Hsu C.; Shih J.-Y.; Yang C.-H.
臺大學術典藏 2022-06-27T07:06:22Z Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2022-06-10T06:11:16Z Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2022-06-10T06:11:14Z The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma ZHONG-ZHE LIN; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L.
臺大學術典藏 2022-06-10T06:11:14Z Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; ZHONG-ZHE LIN; Chang M.-C.; Hsu C.; Cheng A.-L.
臺大學術典藏 2022-06-10T06:11:13Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; ZHONG-ZHE LIN; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.

显示项目 31-40 / 881 (共89页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目